Prevalence of Cardiovascular Diseases in COPD-OSA Overlap Syndrome Versus COPD Alone: A Systematic Review
Ștefania-Florina Oprea1,2, Ștefan Dumitrache-Rujinski1,2, Camelia Cristina Diaconu1,3,4
1Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, umfcaroldavila.ro.
Background:
Chronic obstructive pulmonary disease (COPD) is frequently associated with cardiovascular comorbidities. Obstructive sleep apnea (OSA) may coexist with COPD, forming the so-called overlap syndrome (OS), and may further increase cardiovascular risk through intermittent hypoxia, systemic inflammation, and sympathetic activation. This systematic review is aimed at synthesizing and comparing the burden of cardiovascular comorbidities in patients with COPD and coexisting OSA versus those with COPD alone, thereby identifying the additional cardiovascular burden associated with OSA and gaps in current knowledge.
Materials And Methods:
A systematic search was conducted in PubMed and Web of Science from inception to 3rd of January 2026, using predefined search terms related to COPD, OSA, and cardiovascular diseases. Only observational studies in adults were included.
Results:
Nineteen studies were included in the final analysis. Most studies had a cross-sectional or retrospective cohort design. Cardiovascular disease was reported as a baseline characteristic in nearly all included studies; however, none evaluated the prevalence of cardiovascular disease as a primary outcome; these conditions were reported mainly as associated comorbidities. Overall, most included studies reported a higher prevalence of cardiovascular diseases-particularly systemic arterial hypertension-in patients with overlap syndrome compared with COPD alone, frequently reaching statistical significance; however, this finding derived from unadjusted comparisons of baseline comorbidities, and no study adjusted for confounders such as age, body mass index, or smoking.
Conclusions:
Although many of the observed differences were statistically significant, they derived from unadjusted comparisons of baseline characteristics, which limits the ability to draw firm conclusions regarding causality. Future studies including larger populations of patients with COPD and OSA are required to accurately determine the prevalence of cardiovascular disease and better describe the relationship between COPD, OSA, and cardiovascular comorbidities.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: